Pyrazoline Compounds

摘要

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: wherein R¹, R², R^3A, R^3B, R⁴, R⁵, R⁶, R⁷, R⁸, and X are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, and intermediates are also disclosed.